All In MedTech

Company

Endotronix

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$116M

7 Form D offerings, 2011 to 2018

Equity

$108M

Stock sold for cash

Debt and convertible notes

$8.1M

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $69.3M raised of $90.8M sought, first sale Sep 14, 2018, 38 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Sep 14, 2018Equity$69.3M$90.8M38Rule 506(b)Form D/A ↗Dec 7, 20202 amendments
Jul 5, 2016Equity$37.1M$37.1M52Rule 506(b)Form D/A ↗Feb 26, 20181 amendment
Jun 18, 2015Debt$3.0M$3.5M25Rule 506(b)Form D/A ↗Dec 31, 20151 amendment

4 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
ENDOTRONIX INC
Headquarters
Lisle, Illinois
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    9 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Endotronix.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT04012944 · 81 participants · Start Jun 26, 2019 · Primary completion Oct 30, 2021

      Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III

      Sites: Aalst, Belgium; Genk, Belgium; Cologne, Germany · 7 sites in all

    • NCT04089059 · 738 participants · Start Jan 10, 2020 · Primary completion Apr 2028

      Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III

      Sites: Birmingham, Alabama; Huntsville, Alabama; Phoenix, Arizona · 74 sites in all

    • NCT05934487 · 1,750 participants (planned) · Start Nov 29, 2023 · Primary completion Sep 2028

      Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class II; Heart Failure NYHA Class III; Heart Failure

      Sites: Phoenix, Arizona; Los Angeles, California; San Francisco, California · 48 sites in all

    3 more trials with a free account

    Reports received

    48

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    7

    15% of reports

    Injury reports

    41

    85% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 240000
    Feb 240000
    Mar 240000
    Apr 240000
    May 240000
    Jun 240000
    Jul 241100
    Aug 241200
    Sep 241400
    Oct 241000
    Nov 241300
    Dec 240200
    Jan 252100
    Feb 250300
    Mar 251000
    Apr 253200
    May 252100
    Jun 252410
    Jul 251200
    Aug 252000
    Sep 256300
    Oct 255200
    Nov 251200
    Dec 251100
    Jan 260100
    Feb 260200
    Mar 260400
    Apr 260700
    May 260500
    Jun 260500
    Jul 260700
    Aug 263200
    Sep 261300
    Oct 261200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    2 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.